Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell CarcinomaEur Urol 2021 Oct 06;[EPub Ahead of Print], M Hagiwara, A Fushimi, K Matsumoto, M Oya
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.